Navigation Links
scPharmaceuticals LLC Announces Strategic Partnership with Sensile Medical to Develop Novel Heart Failure Treatment Aimed to Reduce Readmission Rates
Date:4/7/2013

BOSTON, April 8, 2013 /PRNewswire/ -- scPharmaceuticals LLC today announced that it has entered into a strategic partnership and product development agreement with Sensile Medical Holding AG of Zug, Switzerland to develop an innovative new therapeutic option for patients with heart failure.  The terms of the agreement were not disclosed.

The drug-device combination uses the Sensile SenseCore technology in a wearable minipump that delivers the pharmaceutical drug product under the skin using a very small needle.  The pharmaceutical product is a proprietary reformulation of a proven diuretic that already forms the cornerstone of heart failure therapy.  Diuretics remove excess fluid retained by the body by increasing urinary output.  The diuretic that will be used with the minipump is a novel formulation of the diuretic furosemide, which has been in clinical use for nearly 50 years.  Furosemide is currently used in tablet form or in solution for intravenous administration.  Furosemide required a proprietary reformulation to render it suitable for subcutaneous administration.

Under the product development agreement, Sensile and scPharmaceuticals will collaborate to develop and manufacture minipump devices for use by scPharmaceuticals for its furosemide drug product for subcutaneous administration.  scPharmaceuticals expects to submit its New Drug Application for the furosemide drug device combination no later than Q1 of 2015.

"Hospitalization for heart failure is expected to be one of the most important reasons for the projected increase in health care costs over the next decade as our population ages and the epidemic of obesity and diabetes continues unabated," said Dr. Bertram Pitt , Professor of Medicine Emeritus at the University of Michigan School of Medicine and one of the co-founders of scPharmaceuticals.  "This
'/>"/>

SOURCE scPharmaceuticals LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Hanger, Inc. Announces First Quarter 2013 Earnings Release And Conference Call
2. Sigma-Aldrich Announces Q1 2013 Earnings Conference Call
3. Uroplasty Announces CEO Resignation
4. Cardium Announces $4.0 Million Preferred Stock Financing And Reports On Exchange Listing Compliance
5. MEI Pharma Announces $15.2 Million Registered Offering Of Common Stock
6. EntreMed Announces Changes to Board of Directors and CEO Appointment
7. AstraZeneca Announces Top-Line Results From OSKIRA-1 Phase 3 Study of Fostamatinib in Rheumatoid Arthritis
8. Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2013 Results
9. MedFocusCapital Partners Announces See.Hear.Live.Better! Alliance
10. Regeneron Pharmaceuticals Announces Expansion in New Yorks Hudson Valley
11. Array BioPharma Announces Updates on ARRY-520 Clinical Data at the 2013 International Myeloma Workshop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015  The Mesothelioma ... diagnosed victims of mesothelioma get the best possible ... certain individuals with this rare cancer caused by ... most up-to-date information related to treatment options such ... please call the Mesothelioma Victims Center anytime at ...
(Date:5/22/2015)... R.I. , May 22, 2015 ... once-daily central nervous system stimulant indicated for the ... to patients beginning Summer 2015. ... XR received approval from the U.S. Food and ... is an extended-release formulation of methylphenidate capsule with ...
(Date:5/21/2015)... DUBLIN , May 21, 2015 /PRNewswire/ ... http://www.researchandmarkets.com/research/5x377m/north_american ) has announced the addition of ... by Type (Ankle Replacement, Digit Replacement, Elbow ... - Forecast to 2019" report to ... market for knee replacement was valued at ...
Breaking Medicine Technology:Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6North American Joint Reconstruction Market 2015-2019 - Zimmer Holdings, DePuy Synthes Companies, Stryker, Biomet & Smith & Nephew Dominates the $4.4 Billion Market 2
... (NYSE and SIX: ZMH) announced today it will be participating in the BMO Capital Markets ... August 5, 2010 , at 8:30 a.m. Eastern Time . , ... A live webcast of the presentation can be accessed via Zimmer,s Investor Relations website ... , , ...
... Susquehanna Financial Group, LLLP (SFG), the institutional broker-dealer ... today that Gary Nachman has joined the firm ... Nachman, whose coverage will include names such as Allergan, Cephalon, ... Warner Chilcott , will be based out of SFG,s ...
Cached Medicine Technology:Zimmer Holdings to Present at BMO Capital Markets Tenth Annual Focus on Healthcare Conference 2Susquehanna Financial Group Hires Gary Nachman as Senior Analyst to Cover the Specialty Pharmaceuticals Sector 2Susquehanna Financial Group Hires Gary Nachman as Senior Analyst to Cover the Specialty Pharmaceuticals Sector 3
(Date:5/22/2015)... Philadelphia, PA (PRWEB) May 22, 2015 According ... as a hub for drug related death, totaling almost 2,500 ... number, as reported by state officials, totals 2,489 deaths stemming ... numbers work out, Pennsylvania loses seven people every day to ... Philadelphia has been singled out as one of the most ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Gateway Building ... exterior renovations. The services the company specialize in include ... remodeling, basements, pool houses and much more. , ... by the owner of the company. It includes two ... The design was thought out to be used with ...
(Date:5/22/2015)... sweetFrog Enterprises, LLC. is pleased to announce the opening of ... 16th sweetFrog store located in the Lone Star State. The ... Inc. 500 list of fastest growing companies in 2014. ... for 20 years and love the natural beauty and friendly ... Palestine, sweetFrog locations. “We are really excited about giving back ...
(Date:5/22/2015)... Wimbledon Health Partners, the leading on-site ... and NCV testing , is proud to announce ... American National athlete, to the Wimbledon Athletics division. ... level of testing and information it provides to be ... trainers, this way they can focus on the task ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Ticket Down is ... New York Rangers NHL Eastern Conference Finals Tickets . ... unless specified otherwise in the ticket listing. , For ... are at the top of the Eastern Conference. One of ... its share of ups and downs over the years, but ...
Breaking Medicine News(10 mins):Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:sweetFrog Opens New Location in Jacksonville, Texas 2Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 3
... Blacks 45 percent more likely to die from the disease ... News) -- Despite major progress reducing overall colorectal cancer incidence ... women are still 45 percent more likely than whites to ... a report released Monday by the American Cancer Society. , ...
... of Oregon lab have shed more light on the ... in which a methyl group is attached to DNA, ... , DNA methylation is essential for normal growth and ... in long-term memory, and irregularities in its process are ...
... The Cardiopulmonary Research Science,and Technology Institute (CRSTI), ... for a Phase 2 clinical trial for ... of,Gene Therapy in Cardiac Disease" (CUPID Trial) ... at the American Heart Association Scientific,Sessions 2008. ...
... food costs, many,families are economizing on groceries but one thing ... cents per 8-ounce glass, on a gallon basis, milk,offers more ... the,supermarket -- proving key vitamins and minerals like calcium and ... moms don,t cut milk from,their grocery lists, the National got ...
... CORPUS CHRISTI, Texas, Dec. 15 With rising food costs,many ... not cut,back on is nutrition. At about 25 cents per ... penny than almost any other beverage option in,the supermarket -- ... are important for the entire family. To ensure moms don,t ...
... Dec. 15 With rising food costs, many,families are ... cut back,on is nutrition. At about 25 cents per ... per penny than almost any other beverage option in ... and vitamin D,that are important for the entire family. ...
Cached Medicine News:Health News:Colorectal Cancer Racial Gap Still Growing 2Health News:Work with fungus uncovering keys to DNA methylation 2Health News:CRSTI and Medical City Hospital Dallas Currently Recruiting For a Phase 2 Clinical Trial of MYDICAR(R) for Advanced Heart Failure 2Health News:CRSTI and Medical City Hospital Dallas Currently Recruiting For a Phase 2 Clinical Trial of MYDICAR(R) for Advanced Heart Failure 3Health News:CRSTI and Medical City Hospital Dallas Currently Recruiting For a Phase 2 Clinical Trial of MYDICAR(R) for Advanced Heart Failure 4Health News:Milk is One Beverage Kansas City Can't Afford to Keep Off the Grocery List 2Health News:Milk is One Beverage Kansas City Can't Afford to Keep Off the Grocery List 3Health News:Milk is One Beverage Corpus Christi Can't Afford to Keep Off the Grocery List 2Health News:Milk is One Beverage Corpus Christi Can't Afford to Keep Off the Grocery List 3Health News:Milk is One Beverage Birmingham Can't Afford to Keep Off the Grocery List 2Health News:Milk is One Beverage Birmingham Can't Afford to Keep Off the Grocery List 3
... when it comes to superior immobilization and cervical ... job., ,You already know that the most ... of the c-spine. But what you may not ... Medical's NECLOC ®: provides superior immobilization over the ...
Distinct male and female designs for proper anatomical fit. Hip and pelvic components sized independently. Rigid posterior tongue minimizes pelvic rotation. Available in black or white plastic. Aggre...
... The B3 Triplanar hip joint ... Flexion - extension, abduction - ... on our Boston Post-Op Hip ... our custom Hip Spicas in ...
... the most significant advance in walker design in years. ... where the weight bearing surfaces of the foot rest ... absorbed at the heel strike. The footbed in the ... for added comfort and stability. , ,No leg ...
Medicine Products: